COMMUNIQUÉS West-GlobeNewswire
-
Best ACV Gummies 2026 Report: True Keto Fusion Analyzed in New Year Keto-ACV Industry Analysis
01/01/2026 -
Best CBD Gummies 2026 Consumer Report: Full Spectrum Formulations, Lab Testing Standards, and State Legal Requirements Examined in Consumer Wellness Category Analysis
01/01/2026 -
Caring Heart Placement Announces Expanded Senior Care Advisory Initiatives in Scottsdale, Arizona
01/01/2026 -
Life Line Screening (Updated): What You Need to Know?
01/01/2026 -
Heal N Soothe (Updated): Does It Work For Chronic Pain?
01/01/2026 -
Best Keto Gummies for 2026: BHB Supplement Guide Examines What Consumers Should Know Before Buying
01/01/2026 -
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
31/12/2025 -
Alvotech Secures Term Loan Facility of USD 100 Million
31/12/2025 -
Alvotech Secures Term Loan Facility of USD 100 Million
31/12/2025 -
LuluTox Detox Tea Unveiled: Why Lulutox Tea Being Discussed as the Best Herbal Weight Loss Tea Blend for Women to Burn Fat in 2026
31/12/2025 -
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
31/12/2025 -
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
01/01/2026 -
New Year, New Mission: Oxford Treatment Center Empowers Veterans to Reclaim Their Lives in 2026
31/12/2025 -
Laguna Treatment Center Strengthens Clinical Team with New Behavioral Health Therapist
31/12/2025 -
River Oaks Treatment Center Offers Expanded Mental Health Services as the New Year Brings Increased Focus on Wellness
31/12/2025 -
Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing
31/12/2025 -
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
31/12/2025 -
Valneva et le Serum Institute of India annoncent la fin de leur accord de licence pour le vaccin contre le chikungunya
31/12/2025 -
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
31/12/2025
Pages